|
|
文章數:74 |
KoDō 和牛燒肉適合約會嗎?》公益路愛店推薦|台中10間美食評比 |
| 心情隨筆|家庭親子 2026/04/21 21:43:29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
身為一個熱愛美食、喜歡在城市裡挖掘驚喜的人,臺中公益路一直是我最常出沒的地方之一。這條路可說是「臺中人的美食戰場」,從精緻西餐到創意火鍋,從日式丼飯到義式早午餐,每走幾步,就會有完全不同的特色料理餐廳。 這次我特別花了一整個月,實際造訪了公益路上十間口碑不錯的餐廳。有的是網友熱推的打卡名店,也有隱藏在巷弄裡的小驚喜。我以環境氛圍、口味表現、價格CP值與再訪意願為基準,整理出這篇實測評比。希望能幫正在猶豫去哪裡吃飯的你,找到那一間「吃完會想再來」的餐廳。 評比標準與整理方向
這次我走訪的10家餐廳橫跨不同料理類型,從高質感牛排館到巷弄系早午餐,每一間都有自己獨特的風格。為了讓整體比較更客觀,我依照以下四大面向進行評比,並搭配實際用餐體驗來打分。
整體而言,我希望這份評比不只是「哪家好吃」,而是幫你在不同情境下(約會、家庭聚餐、朋友小聚、商業午餐)都能快速找到合適的選擇。畢竟,美食不只是味覺的滿足,更是一段段與朋友共享的生活記憶。 10間臺中公益路餐廳評比懶人包公益路向來是臺中人聚餐的首選地段,從火鍋、燒肉到中式料理與早午餐,每走幾步就有驚喜。以下是我實際造訪過的10間代表性餐廳清單,橫跨平價、創意、高級各路風格。
一頭牛日式燒肉|炭香濃郁的和牛饗宴,約會聚餐首選
走在公益路上,很難不被 一頭牛日式燒肉 的木質外觀吸引。低調卻不失質感的門面,搭配昏黃燈光與暖色調的內裝,讓人一進門就感受到濃濃的日式職人氛圍。店內空間不大,但桌距規劃得宜,每桌皆設有獨立排煙設備,烤肉時完全不怕滿身油煙味。 餐點特色
一頭牛的靈魂,絕對是他們招牌的「三國和牛拼盤」。 用餐體驗整體節奏掌握得非常好。店員會在你剛想烤下一片肉時貼心遞上夾子、幫忙換烤網,讓人完全不用分心。整場用餐過程就像一場表演,從視覺、嗅覺到味覺都被滿足。 綜合評分
地址:408臺中市南屯區公益路二段162號電話:04-23206800 小結語一頭牛日式燒肉不僅是「吃肉的地方」,更像是一場五感盛宴。從進門那一刻到最後一道甜點,都能感受到他們對細節的用心。 TANG Zhan 湯棧|文青系火鍋代表,麻香湯底與視覺美感並重
在公益路這條美食戰線上,TANG Zhan 湯棧 是讓人一眼就會想走進去的那一種。 餐點特色
湯棧最有名的當然是它的「麻香鍋」。 用餐體驗整體氛圍比一般火鍋店更有質感。 綜合評分
地址:408臺中市南屯區公益路二段248號電話:04-22580617 官網:https://www.facebook.com/TangZhan.tw/ 小結語TANG Zhan 湯棧 把傳統火鍋做出新的樣貌保留臺式鍋物的溫度,又結合現代風格與細節服務,讓吃鍋這件事變得更有品味。 如果你想找一間兼具「好吃、好拍、好放鬆」的火鍋店,湯棧會是公益路上最有風格的選擇之一。 NINI 尼尼臺中店|明亮寬敞的義式早午餐天堂
如果說前兩間是肉食愛好者的天堂,那 NINI 尼尼臺中店 絕對是想放鬆、聊聊天的好地方。餐廳外觀以白色系與大片玻璃窗為主,陽光灑進室內,讓人一踏入就有種度假般的輕盈感。假日早午餐時段特別熱鬧,建議提早訂位。 餐點特色
NINI 的菜單融合義式與臺灣人口味,選擇多樣且份量十足。主打的 松露燉飯 濃郁卻不膩口,米芯保留微Q口感;而 香蒜海鮮義大利麵 則以新鮮白蝦、花枝與淡菜搭配微辣蒜香,口感層次豐富。 用餐體驗店內氣氛輕鬆不拘謹,無論是一個人帶電腦工作、或朋友聚餐,都能找到舒服角落。餐點上桌速度穩定,服務人員態度親切、補水與收盤都非常主動。整體節奏讓人覺得「時間變慢了」,很適合想遠離忙碌日常的人。 綜合評分
地址:40861臺中市南屯區公益路二段18號電話:04-23288498 小結語NINI 尼尼臺中店是一間能讓人放下手機、慢慢吃飯的餐廳。餐點不追求浮誇,而是以「剛剛好」的份量與風味,陪伴每個平凡午後。如果你在找一間能邊吃邊聊天、拍照也漂亮的早午餐店,NINI 會是你在公益路上最不費力的幸福選擇。 加分100%浜中特選昆布鍋物|平價卻用心的湯頭系火鍋,家庭聚餐好選擇
在公益路這條高質感餐廳林立的戰場上,加分100%浜中特選昆布鍋物 走的是截然不同的路線。它沒有浮誇的裝潢、也沒有高價位的套餐,但靠著實在的湯頭與親切的服務,默默吸引許多回頭客。每到用餐時間,總能看到家庭或情侶三兩成群地圍著鍋邊聊天。 餐點特色
主打 北海道浜中昆布湯底,湯頭清澈卻不單薄,越煮越能喝出海藻與柴魚的自然香氣。 用餐體驗整體氛圍偏家庭取向,桌距寬敞、座位舒適,帶小孩來也不覺擁擠。店員態度親切,補湯、收盤都很勤快,給人一種「被照顧著」的安心感。 綜合評分
地址:403臺中市西區公益路288號電話:0910855180 小結語加分100%浜中特選昆布鍋物是一間「不浮誇、但會讓人想再訪」的火鍋店。它不追求豪華擺盤,而是用最簡單的湯頭與新鮮食材,傳遞出家常卻不平凡的溫度。 印月餐廳|中式料理的藝術演繹,宴客與家庭聚會首選
說到臺中公益路的中式料理代表,印月餐廳 絕對是榜上有名。這間開業多年的餐廳以「中菜西吃」的概念聞名,把傳統中式料理以現代手法重新詮釋。從建築外觀到餐具擺設,每個細節都散發著低調的典雅氣息。 餐點特色
印月最令人印象深刻的是他們將傳統中菜融入創意手法。 用餐體驗服務方面完全對得起餐廳的高級定位。從入座、點餐到上菜節奏,都拿捏得恰如其分。每道菜都會有服務人員細心介紹食材與吃法,讓人感受到「被款待」的尊榮感。 綜合評分
地址:408臺中市南屯區公益路二段818號電話:0422511155 小結語印月餐廳是一間「不只吃飯,更像品味生活」的地方。 KoDō 和牛燒肉|極致職人精神,專為儀式感與頂級味覺而生
若要形容 KoDō 和牛燒肉 的用餐體驗,一句話足以總結——「像在欣賞一場關於肉的表演」。 餐點特色
這裡主打 日本A5和牛冷藏肉,以「精切厚燒」的方式呈現。 用餐體驗KoDō 的最大特色是「儀式感」。 綜合評分
地址:403臺中市西區公益路260號電話:0423220312 官網:https://www.facebook.com/kodo2018/ 小結語KoDō 和牛燒肉不是日常餐廳,而是一場體驗。 永心鳳茶|在茶香裡用餐的優雅時光,臺味早午餐的新詮釋
走進 永心鳳茶公益店,彷彿進入一間有氣質的茶館。 餐點特色
永心鳳茶的餐點結合中式靈魂與西式擺盤,無論是「炸雞腿飯」還是「紅玉紅茶拿鐵」,都能讓人感受到熟悉卻不平凡的味道。 用餐體驗店內服務人員態度溫和,對茶品介紹詳盡。上餐節奏剛好,不急不徐。 綜合評分
地址:40360臺中市西區公益路68號三樓(勤美誠品)電話:0423221118 小結語永心鳳茶讓人重新定義「臺味」。 三希樓|老饕級江浙功夫菜,穩重又帶人情味的中式饗宴
位於公益路上的 三希樓 是許多臺中老饕的口袋名單。 餐點特色
三希樓的菜色以 江浙與港式料理 為主,兼顧傳統與現代風味。 用餐體驗三希樓的服務給人一種老派但貼心的感覺。 綜合評分
地址:408臺中市南屯區公益路二段95號電話:0423202322 官網:https://www.sanxilou.com.tw/ 小結語三希樓是一間「吃得出功夫」的餐廳。 一笈壽司|低調奢華的無菜單日料,職人手藝詮釋旬味極致
在熱鬧的公益路上,一笈壽司 低調得幾乎不顯眼。 餐點特色
一笈壽司採 Omakase(無菜單料理) 形式,每一餐都由主廚根據當日食材設計。 用餐體驗整場用餐約90分鐘,節奏緩慢但沉穩。 綜合評分
地址:408臺中市南屯區公益路二段25號電話:0423206368 官網:https://www.facebook.com/YIJI.sushi/ 小結語一笈壽司是一間真正讓人「放慢呼吸」的餐廳。 茶六燒肉堂|人氣爆棚的和牛燒肉聖地,肉香與幸福感同時滿分
若要票選公益路上「最難訂位」的餐廳,茶六燒肉堂 絕對名列前茅。 餐點特色
茶六主打 和牛燒肉套餐,價格約落在 $700–$1000 間,份量與品質兼具。 用餐體驗茶六的服務效率相當高。店員親切、換網勤快、補水速度快,整場用餐流程流暢無壓力。 綜合評分
地址:403臺中市西區公益路268號電話:0423281167 官網:https://inline.app/booking/-L93VSXuz8o86ahWDRg0:inline-live-karuizawa/-LUYUEIOYwa7GCUpAFWA 小結語茶六燒肉堂用「穩定品質+輕奢氛圍」抓住了臺中年輕族群的心。 吃完10家公益路餐廳後的心得與結語吃完這十家餐廳後,臺中公益路不只是一條美食街,而是一段生活風景線。 有的餐廳講究細膩與儀式感,像 一頭牛日式燒肉 與 一笈壽司,讓人感受到食材最純粹的美好 有的則以親切與溫度打動人心,像 加分昆布鍋物、永心鳳茶,讓人明白吃飯不只是為了飽足,而是一種被照顧的幸福。 而像茶六燒肉堂、TANG Zhan 湯棧 這類人氣名店,則用穩定的品質與熱絡的氛圍,成為許多臺中人心中「想吃肉就去那裡」的代名詞。 這十家店,構成了公益路最動人的縮影 有華麗的,也有溫柔的;有傳統的,也有創新的。 每一家都在自己的風格裡發光,讓人吃到的不只是料理,而是一種生活的溫度與節奏。 對我而言,這不僅是一場美食旅程,更是一趟關於「臺中味道」的回憶之旅。 FAQ:關於臺中公益路美食常見問題Q1:公益路哪一區的餐廳最集中? Q2:需要提前訂位嗎? 最後的話若要用一句話形容這趟美食之旅,我會說: 茶六燒肉堂年末聚餐推薦嗎? 如果你也和我一樣喜歡用味蕾探索一座城市,那就把這篇公益路美食攻略收藏起來吧。一頭牛日式燒肉尾牙拍照效果好嗎? 無論是約會、慶生、家庭聚餐,或只是想犒賞一下辛苦的自己——這條路上永遠會有一間剛剛好的餐廳在等你。TANG Zhan 湯棧春酒活動適合在這裡辦嗎? 下一餐,不妨從這10家開始。一笈壽司人潮很多嗎? 打開手機、約上朋友,讓公益路成為你生活裡最容易抵達的小確幸。TANG Zhan 湯棧有提供尾牙方案嗎? 如果你有私心愛店,也歡迎留言分享,茶六燒肉堂平日好排隊嗎? 你的推薦,可能讓我下一趟美食旅程變得更精彩。KoDō 和牛燒肉春酒場面夠體面嗎? Researchers in Wyoming have discovered that cyclotides from violets, particularly kalata B1, can boost the potency of TMZ chemotherapy in treating glioblastoma, offering potential for improved treatment options. Synthetic versions of kalata B1 are now being produced for further testing. Violets’ cyclotides could revolutionize glioblastoma treatment by boosting chemotherapy efficacy, now advancing to mouse model testing. Glioblastoma is one of the deadliest brain diseases known. More than 45% of brain cancers are gliomas. Only half of glioblastoma patients respond to the FDA-approved chemotherapy Temozolomide (TMZ). Even for those patients, the cancer cells quickly evolve resistance. The majority of patients pass away within 12 to 16 months after diagnosis, and few make it beyond five years. However, a glimmer of hope for patients is emerging from an unexpected source: Jackson Hole, Wyoming, where scientists at the non-profit Brain Chemistry Labs have been researching molecules found in violets. Wyoming violets. Credit: Dr. Paul Alan Cox, Brain Chemistry Labs Cyclotides: Nature’s Cancer Fighters Violets produce a dazzling suite of small circular peptides called cyclotides. They roughly appear in shape “like floppy frisbees,” says Dr. Samantha L. Gerlach. “They have been found active in the test tube against certain types of human cancer cells.” Disulfide crosslinks which maintain the shape of cyclotides may help them create pores in the membranes of cancer cells. Within the plant, cyclotides provide protection against insect herbivores, fungal infections, and viruses. Cyclotides were originally discovered from an herbal tea used by indigenous people in Africa to ease the course of childbirth. The tea was made from a plant they call kalata-kalata, which scientists call Oldenlandia affinis. Violet researcher Dr. Samantha Gerlach at Brain Chemistry Labs. Credit: Dr. Paul Alan Cox, Brain Chemistry Labs Breakthrough with Cyclotide Kalata B1 In a new study published in Biomedicines, an international team led by scientists in Jackson Hole announced that the cyclotide kalata B1 turbocharges the activity of the chemotherapy TMZ, decreasing the amount necessary to kill glioblastoma cells by over ten-fold. Senior author Dr. Gerlach and her colleagues demonstrated that a synthetic version of kalata B1 has equal efficacy to the natural molecule. “While kalata B1 commonly occurs in violet species, extraction from plant material yields only minuscule amounts,” Gerlach states. “Working day and night for months, the minimal quantities we obtain are insufficient for clinical research.” Synthetic Production and Future Research Through a collaboration with CSBio in California, the scientists were able to obtain much larger quantities of the synthetic version that were sufficient for testing in mouse models of glioblastoma. The structure and efficacy of synthetic kalata B1 were found to be equivalent in all respects to the naturally occurring molecule. Dr. Krish Krishnan at California State University, Fresno used Nuclear Magnetic Resonance (NMR) spectroscopy to confirm the shape and folding of the synthetic molecule. “Our cell data suggest that we can now move forward with the synthetic version in mice models,” Dr. Rachael Dunlop at the Brain Chemistry Labs stated. This next step of testing in mice will occur in Vienna, Austria. While Brain Chemistry Labs Director Dr. Paul Alan Cox believes that the advent of synthetic kalata B1 could be a major step forward, he is cautious about overstating the significance for patients. “We are still a long ways from clinical trials, but now the way is clear to determine if it might be safe for further testing.” Reference: “Kalata B1 Enhances Temozolomide Toxicity to Glioblastoma Cells” by Samantha L. Gerlach, James S. Metcalf, Rachael A. Dunlop, Sandra Anne Banack, Cheenou Her, Viswanathan V. Krishnan, Ulf Göransson, Sunithi Gunasekera, Blazej Slazak and Paul Alan Cox, 27 September 2024, Biomedicines. DOI: 10.3390/biomedicines12102216 Lab-grown human nephron progenitor cells. Credit: Biao Huang/Li Lab Researchers at USC have advanced kidney research by developing a new method to cultivate nephron progenitor cells from human stem cells. This method simplifies the process and enhances applications in disease modeling and drug discovery. In a new study published today in Cell Stem Cell, USC scientists report significant progress in cultivating nephron progenitor cells (NPCs), the cells destined to form the kidney’s filtration system, the nephrons. NPCs hold immense promise for understanding kidney development, modeling diseases, and discovering new treatments. “By enhancing our capability to grow NPCs from human stem cells, we create a new avenue for understanding and combating congenital kidney diseases and cancer,” said corresponding and lead author Zhongwei Li, an assistant professor of medicine, and stem cell biology and regenerative medicine at the Keck School of Medicine of USC. In the study, funded in part by the National Institutes of Health, Li Lab postdocs Biao Huang and Zipeng Zeng and their collaborators improved the chemical cocktail for generating and growing NPCs in the laboratory. This improved cocktail enables the sustained growth of both mouse and human NPCs in a simple 2-dimensional format. This marks a major improvement over the previous 3-dimensional system, which was not only more cumbersome, but also limited the ability to perform genome editing on the cells. The cocktail also enables the expansion of induced NPCs (iNPCs) from human pluripotent stem cells. These iNPCs closely resemble native human NPCs. With this approach, iNPCs can be generated from any individual starting with a simple blood or skin biopsy. This approach will facilitate the creation of patient-specific kidney disease models and enhance efforts to identify nephron targeted drugs. Moreover, the cocktail is powerful enough to reprogram a differentiated type of kidney cell known as a podocyte into an NPC-like state. Demonstrating the practical applications of their breakthrough, the scientists performed genome editing on the NPCs to screen for genes related to kidney development and disease. This screening identified previously implicated genes, as well as novel candidates. In a further demonstration, the scientists introduced the genetic mutations responsible for polycystic kidney disease (PKD) into the NPCs. These NPCs developed into mini-kidney structures, known as organoids, exhibiting cysts—the hallmark symptom of PKD. The team then used the organoids to screen for drug-like compounds that inhibited cyst formation. “This breakthrough has potential for advancing kidney research in many critical ways—from accelerating drug discovery to unraveling the genetic underpinnings of kidney development, disease, and cancer,” said Li. “Importantly, it also provides supplies of NPCs as critical building blocks to build synthetic kidneys for kidney replacement therapy.” Reference: “Long-term expandable mouse and human-induced nephron progenitor cells enable kidney organoid maturation and modeling of plasticity and disease” by Biao Huang, Zipeng Zeng, Sunghyun Kim, Connor C. Fausto, Kari Koppitch, Hui Li, Zexu Li, Xi Chen, Jinjin Guo, Chennan C. Zhang, Tianyi Ma, Pedro Medina, Megan E. Schreiber, Mateo W. Xia, Ariel C. Vonk, Tianyuan Xiang, Tadrushi Patel, Yidan Li, Riana K. Parvez, Balint Der, Jyun Hao Chen, Zhenqing Liu, Matthew E. Thornton, Brendan H. Grubbs, Yarui Diao, Yali Dou, Ksenia Gnedeva, Qilong Ying, Nuria M. Pastor-Soler, Teng Fei, Kenneth R. Hallows, Nils O. Lindström, Andrew P. McMahon and Zhongwei Li, 30 April 2024, Cell Stem Cell. DOI: 10.1016/j.stem.2024.04.002 Additional co-authors include: Sunghyun Kim, Connor C. Fausto, Kari Koppitch, Hui Li, Xi Chen, Jinjin Guo, Chennan C. Zhang, Tianyi Ma, Pedro Medina, Megan E. Schreiber, Mateo W. Xia, Ariel C. Vonk, Tianyuan Xiang, Tadrushi Patel, Yidan Li, Riana K. Parvez, Jyun Hao Chen, Matthew E. Thornton, Brendan H. Grubbs, Yali Dou, Ksenia Gnedeva, Qi-Long Ying, Nuria M. Pastor-Soler, Kenneth R. Hallows, Nils O. Lindström, and Andy McMahon from USC; Zexu Li and Teng Fei from Northeastern University in Shenyang, China; Balint Der from USC and Semmelweis University in Budapest, Hungary; Zhenqing Liu from City of Hope; and Yarui Diao from the Duke University School of Medicine. Eighty percent of this work was supported by federal funding from the National Institutes of Health (NIH) (grant numbers DK054364, and T32HD060549) and the NIH Common Fund’s High-Risk High-Reward Research program (grant number DP2DK135739). Additional support came from University Kidney Research Organization (UKRO) foundation funding, a Keck School of Medicine of USC Dean’s Pilot Award, a USC Stem Cell Challenge Grant, a USC Provost’s Undergrad Research Fellowship, a Chan Zuckerberg Initiative seed network grant (CZIF2019-002430), and a CIRM Bridges Award. McMahon is a scientific advisor or consultant for Novartis, eGENESIS, Trestle Biotherapeutics, GentiBio, and IVIVA Medical. Li, Huang, Zeng, McMahon, Hallows, and Pastor-Soler have applied for intellectual property protection for technologies described in this study. Structure generated entirely from human stem cells that closely mimics morphology of human embryo. Credit: Sozen, Jorgensen, and Zernicka-Goetz Research on human embryos is vital to understanding the earliest stages of human development. Currently, this research is conducted on surplus embryos willingly donated by individuals who have undergone in vitro fertilization. Nevertheless, this research is limited by the availability of embryos and strict international ethical time limits on how long an embryo is allowed to develop in the laboratory (14 days maximum). Now, Caltech researchers have created embryo-like structures out of human stem cells. In contrast to natural embryos that are formed by a combination of sperm and egg, these structures are formed by combining so-called pluripotent stem cells, which have the ability to develop into specialized types of cells. Though these embryo-like structures have some key differences from real embryos, the technology to create them will be critical in answering open questions about human development without the need for donated embryos. Magdalena Zernicka-Goetz. Credit: Zernicka-Goetz lab The research was conducted in the laboratory of Magdalena Zernicka-Goetz, Bren Professor of Biology and Biological Engineering at Caltech, and is described in a paper published in the journal Nature Communications on September 21, 2021. The structures are made from a type of pluripotent stem cell that gives rise to distinct types of cells that then self-assemble into a structure with morphology clearly reminiscent of that of an embryo, which has distinct embryonic and extra-embryonic tissues. The pluripotent stem cells were initially isolated from a real human embryo by other researchers and have since been maintained in a laboratory environment. Remarkably, the cells can still “remember” how to assemble into an embryo when supported by the right environmental conditions. “The ability to assemble the basic structure of the embryo seems to be a built-in property of these earliest embryonic cells that they are simply unable to ‘forget,'” says Zernicka-Goetz. “Nevertheless, either their memory is not absolutely precise or we don’t yet have the best method of helping the cells recover their memories. We still have further work to do before we can get human stem cells to achieve the developmental accuracy that is possible with their equivalent mouse stem cell counterparts.” The ability to generate embryo-like structures from stem cells means that additional donated embryos are not needed; in addition, the structures can be created in large quantities. Thus, this model system may lead to breakthroughs in the understanding of early embryonic development that are not constrained by the limited availability of human embryos. For example, it will be possible to perturb particular genes and study the resulting impact on the developmental process. Additionally, this system can be used to understand how different cellular components coordinate their development at very early stages and the impact of this cellular cross-talk upon later developmental stages. Reference: “Reconstructing aspects of human embryogenesis with pluripotent stem cells” by Berna Sozen, Victoria Jorgensen, Bailey A. T. Weatherbee, Sisi Chen, Meng Zhu and Magdalena Zernicka-Goetz, 21 September 2021, Nature Communications. DOI: 10.1038/s41467-021-25853-4 Former Caltech postdoctoral scholar Berna Sozen, now at Yale University, and Caltech graduate student Victoria Jorgensen are the study’s first authors. In addition to Zernicka-Goetz, additional co-authors are Bailey Weatherbee and Meng Zhu, both members of Zernicka-Goetz’s laboratory at the University of Cambridge, and Caltech senior research scientist Sisi Chen. Funding was provided by the Wellcome Trust, the Open Philanthropy/Silicon Valley Community Foundation, the Weston Havens Foundation, and the Shurl and Kay Curci Foundation. Magdalena Zernicka-Goetz is an affiliated faculty member with the Tianqiao and Chrissy Chen Institute for Neuroscience at Caltech. RRG455KLJIEVEWWF |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 最新創作 |
|
||||
|
||||
|
||||
|
||||
|
||||



























